Anabolism – Talk Bio

Can Element Biosciences Challenge Illumina in the DNA Sequencing Market?

10 months ago talkbio0Tagged ABC, Anabolism, Avidity Base Chemistry, Aviti sequencer, Biotechnology, Cloudbreak, competition, DNA Sequence, Genomics, High-Throughput Nucleotide Sequencing, Illumina, Market, SBS, Sequence Analysis

Element Biosciences, Illumina, DNA sequencing, next-generation sequencing (NGS), Avidity Base Chemistry (ABC), sequencing by synthesis (SBS), Cloudbreak, Aviti sequencer, genomics, biotechnology, market competition

Formation Bio Secures $372M Megaround to In-License Over 10 Drugs

10 months ago talkbio0Tagged Anabolism, Bio, biotech, in-license, Megaround

Formation Bio, Megaround, In-License, Drugs, Biotech, AI-Focused

Revolutionizing Drug Discovery: Sanofi, OpenAI, and Formation Bio Join Forces

11 months ago talkbio0Tagged Anabolism, Artificial Intelligence, Bio, Drug Development, Drug Discovery, healthcare innovation, OpenAI, Partnership, sanofi

Sanofi, OpenAI, Formation Bio, AI, drug development, partnership, drug discovery, pharmaceuticals, artificial intelligence, healthcare innovation.